Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
General Infectious Disease
•
Primary Care
•
General Primary Care
•
Public Health & General Preventive Medicine
How do you approach vaccine hesitancy with patients who avoid one particular vaccine (i.e., influenza) but not others?
Related Questions
What factors do you consider when choosing between baloxavir and oseltamivir for treating patients with influenza?
How have you integrated the new HPV self-swab collection into your routine cervical cancer screening, particularly in those with prior abnormal results?
Do you provide empiric doxycycline for Lyme Disease to asymptomatic patients after a tick bite who haven't developed Erythema migrans or are not sure it was an Ixodes tick?
How do you approach patients who request general "hormone testing" without any medical reason to do so?
Would you empirically cover anaerobic organisms when treating non-purulent facial cellulitis if oral source (e.g., mucocutaneous lesion) was suspected?
What is your approach to a situation where DILI is suspected secondary to an important medication (e.g., anticoagulation, antibiotics, etc.), but the diagnosis is uncertain and the liver injury is relatively mild?
What is your preferred laboratory test to assess treatment response or infection resolution in patients with bacterial pneumonia?
Do you prescribe GLP-1 agonists to diabetic patients admitted with minor CVA or TIA for secondary stroke prevention, as suggested by the LAMP trial?
How do you approach balancing the risks and benefits of elective surgery with patients who have multiple co-morbidities (e.g., frailty, chronic kidney disease, and COPD), when standard risk calculators do not capture the full complexity of their condition?
What do you think about chronic suppressive therapy for HSV-2 in a patient with positive antibodies but no prior clinical outbreak?
